Heron Therapeutics Inc (NASDAQ:HRTX)
| 0.9979 Delayed Data As of 3:58pm ET |  +0.0168 / +1.71%Today’s Change | 0.95 Today|||52-Week Range 4.68 | -60.08% Year-to-Date |
Latest HRTX News | Press Releases
No recent news for Heron Therapeutics Inc.
Today’s Trading
| Previous close | 0.98 |
| Today’s open | 1.00 |
| Day’s range | 0.97 - 1.05 |
| Volume | 21,541 |
| Average volume (3 months) | 1,977,522 |
| Market cap | $141.5M |
Data as of 3:58pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | +25.40% |
| Earnings growth (this year) | +47.31% |
| Earnings growth (next 5 years) | +47.50% |
| Revenue growth (last year) | +24.70% |
| P/E ratio | NM |
| Price/Sales | 2.53 |
| Price/Book | 8.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALTAltimmune Inc | +0.02 | +0.60% |
| INMBINmune Bio Inc | -0.04 | -0.56% |
| MRSNMersana Therapeutics... | -0.00 | -0.40% |
| SGMOSangamo Therapeutics... | -0.01 | -1.98% |
Data as of 3:59pm ET, 09/26/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $107.7M |
| Annual profit (last year) | -$182.0M |
| Net profit margin | -169.05% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
